Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516628 | SCV000616275 | uncertain significance | not provided | 2018-03-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083496 | SCV000755401 | benign | Cohen syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000516628 | SCV001751750 | likely benign | not provided | 2020-08-26 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV001083496 | SCV002496028 | uncertain significance | Cohen syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | VPS13B NM_017890.4 exon 42 p.Val2579Leu (c.7735G>C): This variant has not been reported in the literature but is present in 0.1% (20/15276) of Latino alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/8-99778912-G-C?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:448878). This variant amino acid Leucine (Leu) is present in several species including multiple mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV002404336 | SCV002672133 | benign | Inborn genetic diseases | 2017-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003915464 | SCV004734429 | likely benign | VPS13B-related disorder | 2021-05-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |